TNF and cancer: Furthermore, according to the analysis, we found that there was evidence of heterogeneity in the association between TNF-α-238 polymorphism and risk for cancers among the overall 34 and stratified studies: I2 = 77% in overall populations, I2 = 75% in Caucasus populations and I2 = 79% in Asian populations.